{"id":"https://genegraph.clinicalgenome.org/r/726e752c-1774-4025-ad60-9f23c3ea87f1v1.0","type":"EvidenceStrengthAssertion","dc:description":"NUP205 was first reported in relation to autosomal recessive nephrotic syndrome 13  in 2016. (Braun et al., PMID: 26878725). Nucleoporins are essential components of the nuclear pore complex (NPC)1. Only a few diseases have been attributed to NPC dysfunction (Braun et al., PMID: 26878725)At least one pathogenic missense variant has been reported in humans. The p.Phe1995Ser was seen in two siblings with unrelated parents. In vitro functional expression studies showed that the mutation abrogated the interaction of NUP205 with NUP93 (PMID: 26878725)\nIn summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship.This classification was approved by the ClinGen Glomerulopathy GCEP on the meeting September 27th 2022  (SOP Version 9)\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/726e752c-1774-4025-ad60-9f23c3ea87f1","GCISnapshot":"https://genegraph.clinicalgenome.org/r/31bb58ab-3105-4a05-a0ef-6534692e9be7","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/31bb58ab-3105-4a05-a0ef-6534692e9be7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10068","date":"2025-09-24T22:00:10.289Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/31bb58ab-3105-4a05-a0ef-6534692e9be7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10068","date":"2022-09-27T18:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31bb58ab-3105-4a05-a0ef-6534692e9be7_experimental_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/31bb58ab-3105-4a05-a0ef-6534692e9be7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/614c11d4-94e0-4659-8ce5-3723fc1e1a18_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d92e31d-ce5c-4686-a3bc-f3ee0a779681","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d92e31d-ce5c-4686-a3bc-f3ee0a779681_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In vitro functional expression studies showed that the mutation abrogated the interaction of NUP205 with NUP93 ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0d92e31d-ce5c-4686-a3bc-f3ee0a779681_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26878725","allele":{"id":"https://genegraph.clinicalgenome.org/r/36c173ef-4728-460d-824d-e3375e04c645","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015135.3(NUP205):c.5984T>C (p.Phe1995Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357231"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/614c11d4-94e0-4659-8ce5-3723fc1e1a18","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26878725","rdfs:label":"A1733","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/36c173ef-4728-460d-824d-e3375e04c645"},"firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0012588","obo:HP_0000097"],"secondTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0d92e31d-ce5c-4686-a3bc-f3ee0a779681_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1}],"evidenceStrength":"Limited","sequence":11821,"specifiedBy":"GeneValidityCriteria9","strengthScore":1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/4S3H21YaSUw","type":"GeneValidityProposition","disease":"obo:MONDO_0014818","gene":"hgnc:18658","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_31bb58ab-3105-4a05-a0ef-6534692e9be7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}